{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:16:39Z","timestamp":1790320599688,"version":"4.1.0"},"reference-count":45,"publisher":"American Society for Microbiology","issue":"7","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2007,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p><jats:italic>Bordetella pertussis<\/jats:italic>is the causative agent of pertussis (whooping cough). Despite high vaccination coverage, pertussis remains a significant disease in many countries. Besides vaccination, transient carriage of<jats:italic>Bordetella<\/jats:italic>spp. or other cross-reacting organisms adds to the immunity against pertussis. However, the various immunological mechanisms conferring protection remain largely unknown. In this study, paired serum samples from 464 healthy Norwegian military recruits were collected, the first at enrolment and the second about 8 months later. The prevalence of pertussis during military service was examined by comparing the paired serum samples for immunoglobulin G (IgG) antibodies against pertussis toxin (PT) by enzyme-linked immunosorbent assay (ELISA). Seventy-eight percent of the recruits had low levels of IgG antibodies against PT in both samples. Conversely, 8.4% of the recruits demonstrated high anti-PT IgG levels in the first sample, indicative of recent pertussis prior to enrolment. One recruit experienced seroconversion, indicating pertussis during service. A subset of 248 serum samples with low, medium, and high anti-PT IgG titers were analyzed by a different ELISA kit for IgG and IgA antibodies against PT and filamentous hemagglutinin (FHA) and for opsonophagocytic activity (OPA), for induction of C3b deposition products, and for IgG binding with live<jats:italic>B. pertussis<\/jats:italic>as the antigen. We observed high correlations between OPA and IgG against live bacteria (<jats:italic>r<\/jats:italic>= 0.83), between OPA and IgG anti-FHA (<jats:italic>r<\/jats:italic>= 0.79), between OPA and anti-PT IgG (<jats:italic>r<\/jats:italic>= 0.68), and between OPA and C3b binding (<jats:italic>r<\/jats:italic>= 0.70) (<jats:italic>P<\/jats:italic>&lt; 0.0001 for all). Anti-PT IgA did not correlate closely with the other assays.<\/jats:p>","DOI":"10.1128\/cvi.00081-07","type":"journal-article","created":{"date-parts":[[2007,5,17]],"date-time":"2007-05-17T00:54:46Z","timestamp":1179363286000},"page":"855-862","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":19,"title":["Opsonophagocytic Activity and Other Serological Indications of<i>Bordetella pertussis<\/i>Infection in Military Recruits in Norway"],"prefix":"10.1128","volume":"14","author":[{"given":"Audun","family":"Aase","sequence":"first","affiliation":[{"name":"Department of Bacteriology and Immunology, Norwegian Institute of Public Health, Oslo, Norway"},{"name":"General Practice Branch, Armed Forces Medical Services, Oslo, Norway"},{"name":"Institute of Microbiology, Armed Forces Medical Services, Oslo, Norway"},{"name":"Ulleva\u030al University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tove Karin","family":"Herstad","sequence":"additional","affiliation":[{"name":"Department of Bacteriology and Immunology, Norwegian Institute of Public Health, Oslo, Norway"},{"name":"General Practice Branch, Armed Forces Medical Services, Oslo, Norway"},{"name":"Institute of Microbiology, Armed Forces Medical Services, Oslo, Norway"},{"name":"Ulleva\u030al University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Merino","sequence":"additional","affiliation":[{"name":"Department of Bacteriology and Immunology, Norwegian Institute of Public Health, Oslo, Norway"},{"name":"General Practice Branch, Armed Forces Medical Services, Oslo, Norway"},{"name":"Institute of Microbiology, Armed Forces Medical Services, Oslo, Norway"},{"name":"Ulleva\u030al University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari Torkildsen","family":"Brandsdal","sequence":"additional","affiliation":[{"name":"Department of Bacteriology and Immunology, Norwegian Institute of Public Health, Oslo, Norway"},{"name":"General Practice Branch, Armed Forces Medical Services, Oslo, Norway"},{"name":"Institute of Microbiology, Armed Forces Medical Services, Oslo, Norway"},{"name":"Ulleva\u030al University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn Peter","family":"Berdal","sequence":"additional","affiliation":[{"name":"Department of Bacteriology and Immunology, Norwegian Institute of Public Health, Oslo, Norway"},{"name":"General Practice Branch, Armed Forces Medical Services, Oslo, Norway"},{"name":"Institute of Microbiology, Armed Forces Medical Services, Oslo, Norway"},{"name":"Ulleva\u030al University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erja M.","family":"Aleksandersen","sequence":"additional","affiliation":[{"name":"Department of Bacteriology and Immunology, Norwegian Institute of Public Health, Oslo, Norway"},{"name":"General Practice Branch, Armed Forces Medical Services, Oslo, Norway"},{"name":"Institute of Microbiology, Armed Forces Medical Services, Oslo, Norway"},{"name":"Ulleva\u030al University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg S.","family":"Aaberge","sequence":"additional","affiliation":[{"name":"Department of Bacteriology and Immunology, Norwegian Institute of Public Health, Oslo, Norway"},{"name":"General Practice Branch, Armed Forces Medical Services, Oslo, Norway"},{"name":"Institute of Microbiology, Armed Forces Medical Services, Oslo, Norway"},{"name":"Ulleva\u030al University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1046\/j.1365-3083.1998.00319.x","volume":"47","year":"1998","unstructured":"Aase, A., E. A. Hoiby, and T. E. Michaelsen. 1998. Opsonophagocytic and bactericidal activity mediated by purified IgG subclass antibodies after vaccination with the Norwegian group B meningococcal vaccine. Scand. J. Immunol.47:388-396.","journal-title":"Scand. J. Immunol."},{"key":"e_1_3_1_3_2","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/S0264-410X(02)00774-0","volume":"21","year":"2003","unstructured":"Aase, A., L. M. Naess, R. H. Sandin, T. K. Herstad, F. Oftung, J. Holst, I. L. Haugen, E. A. Hoiby, and T. E. Michaelsen. 2003. Comparison of functional immune responses in humans after intranasal and intramuscular immunisations with outer membrane vesicle vaccines against group B meningococcal disease. Vaccine21:2042-2051.","journal-title":"Vaccine"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.60.4.1302-1313.1992"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.1.403-406.2002"},{"key":"e_1_3_1_6_2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0378-1097(03)00132-0","volume":"220","year":"2003","unstructured":"Barnes, M. G., and A. A. Weiss. 2003. Activation of the complement cascade by Bordetella pertussis. FEMS Microbiol. Lett.220:271-275.","journal-title":"FEMS Microbiol. Lett."},{"key":"e_1_3_1_7_2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1469-0691.1999.tb00520.x","volume":"5","year":"1999","unstructured":"Carlsson, R. M., B. A. Claesson, T. Lagerg\u00e5rd, and B. Trollfors. 1999. Acquisition of serum antibodies against filamentous hemagglutinin and pertactin unrelated to Bordetella pertussis infection. Clin. Microbiol. Infect.5:709-712.","journal-title":"Clin. Microbiol. Infect."},{"key":"e_1_3_1_8_2","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1126\/science.6287574","volume":"217","year":"1982","unstructured":"Confer, D. L., and J. W. Eaton. 1982. Phagocyte impotence caused by an invasive bacterial adenylate cyclase. Science217:948-950.","journal-title":"Science"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.2.800-806.2000"},{"key":"e_1_3_1_10_2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJM199602083340602","volume":"334","year":"1996","unstructured":"Gustafsson, L., H. O. Hallander, P. Olin, E. Reizenstein, and J. Storsaeter. 1996. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N. Engl. J. Med.334:349-355.","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_1_11_2","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1086\/381439","volume":"38","year":"2004","unstructured":"Heininger, U., J. D. Cherry, and K. Stehr. 2004. Serologic response and antibody-titer decay in adults with pertussis. Clin. Infect. Dis.38:591-594.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_1_12_2","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1086\/377283","volume":"188","year":"2003","unstructured":"Hellwig, S. M. M., M. E. Rodriguez, G. A. M. Berbers, J. G. J. V. de Winkel, and F. R. Mooi. 2003. Crucial role of antibodies to pertactin in Bordetella pertussis immunity. J. Infect. Dis.188:738-742.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_13_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/313913","volume":"31","year":"2000","unstructured":"Hodder, S. L., J. D. Cherry, E. A. Mortimer, Jr., A. B. Ford, J. Gornbein, and K. Papp. 2000. Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents. Clin. Infect. Dis.31:7-14.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_1_14_2","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00006454-199506000-00009","volume":"14","year":"1995","unstructured":"Isacson, J., B. Trollfors, J. Taranger, and R. Lagergard. 1995. Acquisition of IgG serum antibodies against 2 Bordetella antigens (filamentous hemagglutinin and pertactin) in children with no symptoms of pertussis. Pediatr. Infect. Dis. J.14:517-521.","journal-title":"Pediatr. Infect. Dis. J."},{"key":"e_1_3_1_15_2","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1165\/ajrcmb.21.3.3478","volume":"21","year":"1999","unstructured":"Jagels, M. A., P. J. Daffern, B. L. Zuraw, and T. E. Hugli. 1999. Mechanisms and regulation of polymorphonuclear leukocyte and eosinophil adherence to human airway epithelial cells. Am. J. Respir. Cell Mol. Biol.21:418-427.","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"e_1_3_1_16_2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s100960050435","volume":"19","year":"2000","unstructured":"Kerr, J. R., and R. C. Matthews. 2000. Bordetella pertussis infection: pathogenesis, diagnosis, management, and the role of protective immunity. Eur. J. Clin. Microbiol. Infect. Dis.19:77-88.","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.2.956-959.2000"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.61.3.807-815.1993"},{"key":"e_1_3_1_19_2","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/S0264-410X(00)00324-8","volume":"19","year":"2001","unstructured":"Michaelsen, T. E., A. Aase, J. Kolberg, E. Wedge, and E. Rosenqvist. 2001. PorB3 outer membrane protein on Neisseria meningitidis is poorly accessible for antibody binding on live bacteria. Vaccine19:1526-1533.","journal-title":"Vaccine"},{"key":"e_1_3_1_20_2","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1086\/374741","volume":"187","year":"2003","unstructured":"Mobberley-Schuman, P. S., B. Connelly, and A. A. Weiss. 2003. Phagocytosis of Bordetella pertussis incubated with convalescent serum. J. Infect. Dis.187:1646-1653.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.11.7317-7323.2005"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.166.1.230-237.1986"},{"key":"e_1_3_1_23_2","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.4049\/jimmunol.145.8.2633","volume":"145","year":"1990","unstructured":"Nourshargh, S., and T. J. Williams. 1990. Evidence that a receptor-operated event on the neutrophil mediates neutrophil accumulation in vivo. Pretreatment of 111In-neutrophils with pertussis toxin in vitro inhibits their accumulation in vivo. J. Immunol.145:2633-2638.","journal-title":"J. Immunol."},{"key":"e_1_3_1_24_2","doi-asserted-by":"crossref","first-page":"S288","DOI":"10.1086\/322564","volume":"33","year":"2001","unstructured":"Olin, P., H. O. Hallander, L. Gustafsson, E. Reizenstein, and J. Storsaeter. 2001. How to make sense of pertussis immunogenicity data. Clin. Infect. Dis.33(Suppl. 4):S288-S291.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng1227"},{"key":"e_1_3_1_26_2","first-page":"17","volume":"21","year":"1991","unstructured":"Persson, C. G., I. Erjefalt, U. Alkner, C. Baumgarten, L. Greiff, B. Gustafsson, A. Luts, U. Pipkorn, F. Sundler, C. Svensson, et al. 1991. Plasma exudation as a first line respiratory mucosal defence. Clin. Exp. Allergy21:17-24.","journal-title":"Clin. Exp. Allergy"},{"key":"e_1_3_1_27_2","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1016\/j.vaccine.2006.01.021","volume":"24","year":"2006","unstructured":"Reynolds, E., B. Walker, D. Xing, J. Southern, C. Asokanathan, B. Dagg, M. Corbel, and E. Miller. 2006. Laboratory investigation of immune responses to acellular pertussis vaccines when used for boosting adolescents after primary immunisation with whole cell pertussis vaccines: a comparison with data from clinical study. Vaccine24:3248-3257.","journal-title":"Vaccine"},{"key":"e_1_3_1_28_2","doi-asserted-by":"crossref","first-page":"6545","DOI":"10.4049\/jimmunol.167.11.6545","volume":"167","year":"2001","unstructured":"Rodriguez, M. E., S. M. Hellwig, D. F. Hozbor, J. Leusen, W. L. van der Pol, and J. G. Van de Winkel. 2001. Fc receptor-mediated immunity against Bordetella pertussis. J. Immunol.167:6545-6551.","journal-title":"J. Immunol."},{"key":"e_1_3_1_29_2","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/BF00368326","volume":"75","year":"1988","unstructured":"Rothe, G., A. Oser, and G. Valet. 1988. Dihydrorhodamine 123: a new flow cytometric indicator for respiratory burst activity in neutrophil granulocytes. Naturwissenschaften75:354-355.","journal-title":"Naturwissenschaften"},{"key":"e_1_3_1_30_2","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1084\/jem.173.5.1143","volume":"173","year":"1991","unstructured":"Saukkonen, K., C. Cabellos, M. Burroughs, S. Prasad, and E. Tuomanen. 1991. Integrin-mediated localization of Bordetella pertussis within macrophages: role in pulmonary colonization. J. Exp. Med.173:1143-1149.","journal-title":"J. Exp. Med."},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.12.7635-7641.2001"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.60.5.2101-2105.1992"},{"key":"e_1_3_1_33_2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/jlb.50.4.321","volume":"50","year":"1991","unstructured":"Steed, L. L., M. Setareh, and R. L. Friedman. 1991. Intracellular survival of virulent Bordetella pertussis in human polymorphonuclear leukocytes. J Leukoc. Biol.50:321-330.","journal-title":"J Leukoc. Biol."},{"key":"e_1_3_1_34_2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1006\/mpat.2001.0488","volume":"32","year":"2002","unstructured":"Stefanelli, P., R. Ippoliti, C. Fazio, and P. Mastrantonio. 2002. Role of immune sera in the in-vitro phagocytosis of Bordetella pertussis strains. Microb. Pathog.32:135-141.","journal-title":"Microb. Pathog."},{"key":"e_1_3_1_35_2","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0264-410X(98)00227-8","volume":"16","year":"1998","unstructured":"Storsaeter, J., H. O. Hallander, L. Gustafsson, and P. Olin. 1998. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine16:1907-1916.","journal-title":"Vaccine"},{"key":"e_1_3_1_36_2","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1016\/S0264-410X(03)00407-9","volume":"21","year":"2003","unstructured":"Storsaeter, J., H. O. Hallander, L. Gustafsson, and P. Olin. 2003. Low levels of antipertussis antibodies plus lack of history of pertussis correlate with susceptibility after household exposure to Bordetella pertussis. Vaccine21:3542-3549.","journal-title":"Vaccine"},{"key":"e_1_3_1_37_2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10096-007-0258-8","volume":"26","year":"2007","unstructured":"Vainio, K., H. H. Samdal, G. Anestad, D. H. Skutlaberg, K. T. Bransdal, R. Mundal, and I. Aaberge. 2007. Seroprevalence of measles among Norwegian military conscripts in 2004. Eur. J. Clin. Microbiol. Infect. Dis.26(3):217-220.","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.3.1050-1055.1999"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.60.8.3303-3308.1992"},{"key":"e_1_3_1_40_2","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1086\/313707","volume":"30","year":"2000","unstructured":"Vincent, J. M., J. D. Cherry, W. F. Nauschuetz, A. Lipton, C. M. Ono, C. N. Costello, L. K. Sakaguchi, G. Hsue, L. A. Jackson, R. Tachdjian, P. A. Cotter, and J. A. Gornbein. 2000. Prolonged afebrile nonproductive cough illnesses in American soldiers in Korea: a serological search for causation. Clin. Infect. Dis.30:534-539.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_1_41_2","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S1473-3099(02)00452-8","volume":"2","year":"2002","unstructured":"von K\u00f6nig, C. H., S. Halperin, M. Riffelmann, and N. Guiso. 2002. Pertussis of adults and infants. Lancet Infect. Dis.2:744-750.","journal-title":"Lancet Infect. Dis."},{"key":"e_1_3_1_42_2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1086\/504803","volume":"43","year":"2006","unstructured":"Ward, J. I., J. D. Cherry, S. J. Chang, S. Partridge, W. Keitel, K. Edwards, M. Lee, J. Treanor, D. P. Greenberg, S. Barenkamp, D. I. Bernstein, and R. Edelman. 2006. Bordetella pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized acellular pertussis vaccine trial (APERT). Clin. Infect. Dis.43:151-157.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.12.7175-7179.2000"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.12.7152-7155.2000"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.3.1735-1739.2000"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.12.7346-7351.2004"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00081-07","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00081-07","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T22:03:44Z","timestamp":1683842624000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00081-07"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["10.1128\/CVI.00081-07"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00081-07","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7]]},"assertion":[{"value":"2007-02-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-05-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}